FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981506768> ?p ?o ?g. }

• W2981506768 endingPage "2580" @default.
• W2981506768 startingPage "2580" @default.
• W2981506768 abstract "The objective was to evaluate the effects of 6 months of supplementation with Altilix®, containing chlorogenic acid and its derivatives, and luteolin and its derivatives, on cardiovascular risk and hepatic markers in subjects with metabolic syndrome (MetS). A randomized, double-blind, placebo-controlled study was performed in 100 subjects with MetS with a follow-up period of 6 months; 50 subjects were randomized to Altilix® (26 men and 24 women, mean age 63 ± 8 years) and the other 50 to placebo (28 men and 22 women, mean age 63 ± 11 years). Anthropometric, cardiometabolic, and hepatic parameters were assessed at baseline and at the end of follow-up. Carotid intima-media thickness and endothelial function were assessed by doppler ultrasound and by flow-mediated dilation of the brachial artery, respectively. The presence and degree of non-alcoholic fatty liver disease (NAFLD) was assessed by the fatty liver index (FLI), and subjects were divided into three subgroups: (1) without NAFLD; (2) with borderline NAFLD; and (3) with NAFLD. After 6 months of Altilix® supplementation, we found a significant improvement vs. placebo in most of the evaluated parameters, including body weight (-2.40% (95% CI -3.79, -1.01); p < 0.001), waist circumference (-2.76% (95% CI -4.55, -0.96); p = 0.003), HbA1c (-0.95% (95% CI -1.22, -0.67); p < 0.001), plasma lipids, FLI (-21.83% (95% CI -27.39, -16.27); p < 0.001), hepatic transaminases, flow-mediated dilation (10.56% (95% CI 5.00, 16.12); p < 0.001), and carotid intima-media thickness (-39.48% (95% CI -47.98, -30.97); p < 0.001). Further, the improvement in cardiometabolic variables was independent of the degree of hepatic steatosis. Altilix® supplementation improved hepatic and cardio-metabolic parameters in MetS subjects. Altilix® supplementation was a beneficial approach in the management of hepatic and cardiometabolic alterations in MetS subjects." @default.
• W2981506768 created "2019-11-01" @default.
• W2981506768 creator A5002357548 @default.
• W2981506768 creator A5017990681 @default.
• W2981506768 creator A5046431472 @default.
• W2981506768 creator A5049777035 @default.
• W2981506768 creator A5049796469 @default.
• W2981506768 creator A5054876477 @default.
• W2981506768 creator A5068440626 @default.
• W2981506768 creator A5078750468 @default.
• W2981506768 creator A5081565938 @default.
• W2981506768 creator A5082733849 @default.
• W2981506768 creator A5084898347 @default.
• W2981506768 creator A5088586382 @default.
• W2981506768 date "2019-10-25" @default.
• W2981506768 modified "2023-10-07" @default.
• W2981506768 title "Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study" @default.
• W2981506768 cites W100183701 @default.
• W2981506768 cites W1455382946 @default.
• W2981506768 cites W1485528518 @default.
• W2981506768 cites W1595565189 @default.
• W2981506768 cites W1915138565 @default.
• W2981506768 cites W1963683487 @default.
• W2981506768 cites W1986694300 @default.
• W2981506768 cites W2001044983 @default.
• W2981506768 cites W2008192274 @default.
• W2981506768 cites W2037043137 @default.
• W2981506768 cites W2049103906 @default.
• W2981506768 cites W2049923191 @default.
• W2981506768 cites W2054618863 @default.
• W2981506768 cites W2055347368 @default.
• W2981506768 cites W2072551239 @default.
• W2981506768 cites W2078356687 @default.
• W2981506768 cites W2078735163 @default.
• W2981506768 cites W2083481977 @default.
• W2981506768 cites W2095985698 @default.
• W2981506768 cites W2096386481 @default.
• W2981506768 cites W2098915888 @default.
• W2981506768 cites W2106285042 @default.
• W2981506768 cites W2111946630 @default.
• W2981506768 cites W2122996236 @default.
• W2981506768 cites W2132146653 @default.
• W2981506768 cites W2143104968 @default.
• W2981506768 cites W2160234571 @default.
• W2981506768 cites W2170470297 @default.
• W2981506768 cites W2173015444 @default.
• W2981506768 cites W2256856541 @default.
• W2981506768 cites W2329902473 @default.
• W2981506768 cites W2343006474 @default.
• W2981506768 cites W2372652110 @default.
• W2981506768 cites W2402599050 @default.
• W2981506768 cites W2411901770 @default.
• W2981506768 cites W2558288750 @default.
• W2981506768 cites W2590082678 @default.
• W2981506768 cites W2592225941 @default.
• W2981506768 cites W2597426747 @default.
• W2981506768 cites W2607031541 @default.
• W2981506768 cites W2613113998 @default.
• W2981506768 cites W2613519169 @default.
• W2981506768 cites W2616283320 @default.
• W2981506768 cites W2626842659 @default.
• W2981506768 cites W2728177312 @default.
• W2981506768 cites W2728777968 @default.
• W2981506768 cites W2737757244 @default.
• W2981506768 cites W2743820880 @default.
• W2981506768 cites W2769691827 @default.
• W2981506768 cites W2791237260 @default.
• W2981506768 cites W2888443845 @default.
• W2981506768 cites W2891299857 @default.
• W2981506768 cites W2897711858 @default.
• W2981506768 cites W3021842026 @default.
• W2981506768 doi "https://doi.org/10.3390/nu11112580" @default.
• W2981506768 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6893885" @default.
• W2981506768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31731527" @default.
• W2981506768 hasPublicationYear "2019" @default.
• W2981506768 type Work @default.
• W2981506768 sameAs 2981506768 @default.
• W2981506768 citedByCount "32" @default.
• W2981506768 countsByYear W29815067682020 @default.
• W2981506768 countsByYear W29815067682021 @default.
• W2981506768 countsByYear W29815067682022 @default.
• W2981506768 countsByYear W29815067682023 @default.
• W2981506768 crossrefType "journal-article" @default.
• W2981506768 hasAuthorship W2981506768A5002357548 @default.
• W2981506768 hasAuthorship W2981506768A5017990681 @default.
• W2981506768 hasAuthorship W2981506768A5046431472 @default.
• W2981506768 hasAuthorship W2981506768A5049777035 @default.
• W2981506768 hasAuthorship W2981506768A5049796469 @default.
• W2981506768 hasAuthorship W2981506768A5054876477 @default.
• W2981506768 hasAuthorship W2981506768A5068440626 @default.
• W2981506768 hasAuthorship W2981506768A5078750468 @default.
• W2981506768 hasAuthorship W2981506768A5081565938 @default.
• W2981506768 hasAuthorship W2981506768A5082733849 @default.
• W2981506768 hasAuthorship W2981506768A5084898347 @default.
• W2981506768 hasAuthorship W2981506768A5088586382 @default.
• W2981506768 hasBestOaLocation W29815067681 @default.
• W2981506768 hasConcept C126322002 @default.
• W2981506768 hasConcept C134018914 @default.

• next